Carpenter Technology (CRS)
NYSEIndustrialsSteelSnapshot 2026-11-04
$292.10-1.56%
Close 2026-11-04 · 1-day change
NYSEIndustrialsSteelSnapshot 2026-11-04
QuarterlyIQ Insights · CRS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -13.8% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 11.0% |
Growth built into the price is above our model estimate.
The price assumes 24.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 9 industry peers · Company calendar date is not available
CRS — General Counsel transition
Dated 2026-10-15
General Counsel — James D. Dee: The filing discloses the planned retirement of the General Counsel with a named internal successor, indicating an orderly succession rather than a sudden loss of leadership.
Why it matters: PEP income fell year over year as Medical sales weakened. A return to the prior-year level would show that the segment is recovering.
Supportive ifPEP reports quarterly operating income of at least $9.4 million, matching Q1 FY26.
Worry ifPEP operating income falls below Q1 FY27's $7.3 million.
Why it matters: Management kept its FY27 operating income outlook at $850 million to $880 million. A Q2 result above its $192 million to $197 million range would support that plan.
Supportive ifQ2 FY27 operating income tops $197 million, and management keeps its FY27 outlook at $850 million or more.
Worry ifQ2 FY27 operating income is under $192 million. Or management cuts its FY27 outlook to under $850 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$157 on $10,000 · ±1.6% | How much price usually moves either way. |
| Bad day | $455 loss on $10,000 · 4.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,478 loss on $10,000 · 54.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.